Kazakhstan vs Lesotho: Treatment success rate for patients treated for MDR-TB
Kazakhstan
84.0%
in 2022
Lesotho
84.0%
in 2022
Kazakhstan rank
38th
Lesotho rank
38th
Treatment success rate for patients treated for MDR-TB over time
- Kazakhstan
- Lesotho
How they compare
Kazakhstan currently reports 84.0% against 84.0% in Lesotho, a difference of 0.0%.
The two have swapped places 3 times across 16 shared years of data; in 2007 it was Kazakhstan ahead.
Kazakhstan ranks 38th and Lesotho ranks 38th of 163 countries.
Kazakhstan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Kazakhstan | Lesotho | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 74.7% | 62.7% | 12.0% | Kazakhstan |
| 2010s | 76.4% | 69.0% | 7.4% | Kazakhstan |
| 2020s | 80.7% | 77.3% | 3.3% | Kazakhstan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher treatment success rate for patients treated for mdr-tb, Kazakhstan or Lesotho?
- Kazakhstan, at 84.0% against 84.0% in Lesotho as of 2022.
- What is the difference in treatment success rate for patients treated for mdr-tb between Kazakhstan and Lesotho?
- 0.0%, with Kazakhstan ahead.
- How many years of comparable data are there for Kazakhstan and Lesotho?
- 16 years are reported by both, from 2007 to 2022.
- How do Kazakhstan and Lesotho rank globally for treatment success rate for patients treated for mdr-tb?
- Kazakhstan ranks 38th and Lesotho ranks 38th of 163 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Treatment success rate for patients treated for MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.